Clincosm LogoSign in Get a demo

Open-Angle Glaucoma

Showing 1 - 25 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Open-angle Glaucoma Trial in Indianapolis (PER-001 Intravitreal Implant - Low Dose, PER-001 Intravitreal Implant - High Dose,

Recruiting
  • Open-angle Glaucoma
  • PER-001 Intravitreal Implant - Low Dose
  • +2 more
  • Indianapolis, Indiana
    MidWest Eye Institute
Apr 25, 2023

Open-angle Glaucoma, OAG Trial in China (XEN45 Glaucoma Treatment System, Trabeculectomy)

Not yet recruiting
  • Open-angle Glaucoma
  • OAG
  • XEN45 Glaucoma Treatment System
  • Trabeculectomy
  • Beijing, Beijing, China
  • +11 more
Apr 18, 2023

Open-Angle Glaucoma Trial in United States (XEN45 (Glaucoma Gel Stent))

Recruiting
  • Open-Angle Glaucoma
  • XEN45 (Glaucoma Gel Stent)
  • Fayetteville, Arkansas
  • +20 more
Dec 22, 2022

Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)

Recruiting
  • Open-angle Glaucoma
  • Ocular Hypertension
  • AGN-193408 SR
  • +3 more
  • Inglewood, California
  • +27 more
Oct 4, 2022

Open-angle Glaucoma Trial in Yerevan (iStent inject, Travoprost)

Completed
  • Open-angle Glaucoma
  • Yerevan, Armenia
    S.V. Malayan Ophthalmological Center
Sep 2, 2022

Open-Angle Glaucoma Trial in Yerevan (iStent and iStent supra)

Completed
  • Open-Angle Glaucoma
  • iStent and iStent supra
  • Yerevan, Armenia
    S.V. Malayan Ophthalmological Center
Sep 2, 2022

Open-angle Glaucoma Trial in Yerevan (One iStent, Two iStent)

Completed
  • Open-angle Glaucoma
  • One iStent
  • Two iStent
  • Yerevan, Armenia
    S.V. Malayan Ophthalmological Center
Aug 29, 2022

Open-angle Glaucoma Trial in Yerevan (iStent, SLT)

Completed
  • Open-angle Glaucoma
  • iStent
  • SLT
  • Yerevan, Armenia
    S.V. Malayan Ophthalmological Center
Aug 29, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))

Recruiting
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost (SR)
  • Sun City, Arizona
  • +112 more
Aug 16, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Nebivolol Ophthalmic Suspension 1 Percent
  • +3 more
  • Newport Beach, California
    Site 0012
Jul 18, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Open-angle Glaucoma Trial (Bimatoprost Sustained Release Implant)

Available
  • Open-angle Glaucoma
  • Bimatoprost Sustained Release Implant
  • (no location specified)
Apr 13, 2022

Open-angle Glaucoma Trial in Wroclaw (5-fluorouracil, Transconjunctival needling, Transconjunctival revision)

Active, not recruiting
  • Open-angle Glaucoma
  • Wrocław, Poland
    Department of Ophthalmology
Mar 27, 2022

Safety Study of Bimatoprost Intracameral Implant (DURYSTA)

Recruiting
  • Open-angle Glaucoma
  • Ocular Hypertension
    • Culver City, California
    • +24 more
    Feb 21, 2022

    Open-angle Glaucoma, Visual Field Trial in Amiens (MEMOPTIC, usual treatment of glaucoma)

    Recruiting
    • Open-angle Glaucoma
    • Visual Field
    • Amiens, France
      CHU Amiens
    Jul 20, 2021

    Open-angle Glaucoma Trial (Selective laser trabeculoplasty (SLT), Latanoprost ophthalmic solution, Timolol ophthalmic solution)

    Withdrawn
    • Open-angle Glaucoma
    • Selective laser trabeculoplasty (SLT)
    • +2 more
    • (no location specified)
    Jun 17, 2021

    Open-angle Glaucoma, Diabetic Retinopathy Trial in New York (GlaucoHealth, GlaucoSelect, Placebo)

    Terminated
    • Open-angle Glaucoma
    • Diabetic Retinopathy
    • New York, New York
      New York Eye and Ear Infirmary of Mount Sinai
    Mar 15, 2021

    Ocular Hypertension, Glaucoma, Open-angle Glaucoma Trial in Germany (i. Fixed combination of latanoprost 0.005% and timolol

    Completed
    • Ocular Hypertension
    • +2 more
    • i. Fixed combination of latanoprost 0.005% and timolol 0.5%
    • +2 more
    • Aachen, Germany
    • +36 more
    Feb 17, 2021

    Open-angle Glaucoma Trial in Thessaloniki (Drug: dorzolamide/timolol, Drug: latanoprost/timolol, dorzolamide/timolol and

    Completed
    • Open-angle Glaucoma
    • Drug: dorzolamide/timolol
    • +3 more
    • Thessaloniki, Greece
      Glaucoma Unit, A University Dept of Ophthalmology
    Dec 16, 2020

    Open-angle Glaucoma Trial in East Melbourne, Melbourne (PA5108)

    Completed
    • Open-angle Glaucoma
    • East Melbourne, Victoria, Australia
    • +1 more
    Sep 14, 2020

    Open-angle Glaucoma Trial in Newport Beach (ANX007)

    Completed
    • Open-angle Glaucoma
    • ANX007
    • Newport Beach, California
      Eye Research Foundation
    Aug 19, 2020

    Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

    Completed
    Has Results
    • Open-Angle Glaucoma
    • Ocular Hypertension
    • bimatoprost 20 µg generation 2
    • +6 more
    • Artesia, California
    • +56 more
    Mar 27, 2020

    Open-angle Glaucoma, Ocular Hypertension Trial in Bedminster (PG324 Ophthalmic Solution 0.02%/0.005%, Netarsudil (AR-13324)

    Completed
    Has Results
    • Open-angle Glaucoma
    • Ocular Hypertension
    • PG324 Ophthalmic Solution 0.02%/0.005%
    • +2 more
    • Bedminster, New Jersey
      Aerie Pharmaceuticals
    May 13, 2019

    Open-angle Glaucoma, Ocular Hypertension Trial in Fort Worth (Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension,

    Terminated
    Has Results
    • Open-angle Glaucoma
    • Ocular Hypertension
    • Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
    • +2 more
    • Fort Worth, Texas
      Contact Alcon for Locations (Europe, Asia, and Latin America)
    May 16, 2019

    Open-angle Glaucoma, Ocular Hypertension Trial in Bedminster (PG324 Ophthalmic Solution 0.02%/0.005%, Netarsudil (AR-13324)

    Completed
    Has Results
    • Open-angle Glaucoma
    • Ocular Hypertension
    • PG324 Ophthalmic Solution 0.02%/0.005%
    • +2 more
    • Bedminster, New Jersey
      Aerie Pharmaceuticals
    May 14, 2019